These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24858487)

  • 1. Timing of cisplatin administration for chemoradiotherapy in transgenic mice bearing lens tumors.
    Kaku S; Ushioda N; Ishii H; Murakami T; Takahashi K; Nakai Y; Shimoya K; Nakamura T
    Oncol Rep; 2014 Jul; 32(1):16-22. PubMed ID: 24858487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications.
    Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1370-7. PubMed ID: 16979836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Dynamic Alternation of Local and Systemic Tumor Immune Microenvironment During Concurrent Chemoradiotherapy of Cervical Cancer: A Prospective Clinical Trial.
    Li R; Liu Y; Yin R; Yin L; Li K; Sun C; Zhou Z; Li P; Tong R; Xue J; Lu Y
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1432-1441. PubMed ID: 33713744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy.
    Sun W; Wang T; Shi F; Wang J; Wang J; Hui B; Zhang Y; Lu J; Chen H; Liu Z
    BMC Cancer; 2015 May; 15():353. PubMed ID: 25935645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Efficacy of Palonosetron Plus Dexamethasone in Preventing Chemoradiotherapy-induced Nausea and Emesis in Patients Receiving Daily Low-dose Cisplatin-based Concurrent Chemoradiotherapy for Uterine Cervical Cancer: A Phase II Study.
    Mitsuhashi A; Usui H; Nishikimi K; Yamamoto N; Hanawa S; Tate S; Watanabe-Nemoto M; Uno T; Shozu M
    Am J Clin Oncol; 2017 Apr; 40(2):118-121. PubMed ID: 25144265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin-based chemotherapy versus cetuximab in concurrent chemoradiotherapy for locally advanced head and neck cancer treatment.
    Hu MH; Wang LW; Lu HJ; Chu PY; Tai SK; Lee TL; Chen MH; Yang MH; Chang PM
    Biomed Res Int; 2014; 2014():904341. PubMed ID: 25110705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066).
    Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
    Int J Gynecol Cancer; 2012 Oct; 22(8):1420-6. PubMed ID: 22932262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily low-dose cisplatin-based concurrent chemoradiotherapy in patients with uterine cervical cancer with emphasis on elderly patients: a phase 2 trial.
    Mitsuhashi A; Uno T; Usui H; Nishikimi K; Yamamoto N; Watanabe M; Tate S; Hirashiki K; Kato K; Yamazawa K; Shozu M
    Int J Gynecol Cancer; 2013 Oct; 23(8):1453-8. PubMed ID: 23266648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily low-dose Cisplatin-based concurrent chemoradiotherapy for the treatment of cervical cancer in patients 70 years or older.
    Hanawa S; Mitsuhashi A; Usui H; Yamamoto N; Watanabe-Nemoto M; Nishikimi K; Uehara T; Tate S; Uno T; Shozu M
    Int J Gynecol Cancer; 2015 Jun; 25(5):891-6. PubMed ID: 25811592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hematological toxicities between innovator and generic cisplatin formulations in cervical cancer patients treated with concurrent chemoradiotherapy.
    Oike T; Ohno T; Noda SE; Sato H; Tamaki T; Kiyohara H; Ando K; Nakano T
    J Radiat Res; 2013 May; 54(3):474-8. PubMed ID: 23242248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and toxicity of different concurrent chemoradiotherapy regimens in the treatment of advanced cervical cancer: A network meta-analysis.
    Fu ZZ; Li K; Peng Y; Zheng Y; Cao LY; Zhang YJ; Sun YM
    Medicine (Baltimore); 2017 Jan; 96(2):e5853. PubMed ID: 28079819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit Study.
    Kagabu M; Shoji T; Murakami K; Omi H; Honda T; Miura F; Yokoyama Y; Tokunaga H; Takano T; Ohta T; Shimizu D; Sato N; Soeda S; Watanabe T; Yamada H; Mizunuma H; Yaegashi N; Nagase S; Tase T; Sugiyama T
    Int J Clin Oncol; 2016 Aug; 21(4):735-740. PubMed ID: 26782958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent chemoradiotherapy for locally advanced esophageal cancer--a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil.
    Hsu CH; Yeh KH; Lui LT; Lee YC; Bu CF; Wang HP; Lin JT; Cheng AL
    Anticancer Res; 1999; 19(5C):4463-7. PubMed ID: 10650793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why Concurrent CDDP and Radiotherapy Has Synergistic Antitumor Effects: A Review of In Vitro Experimental and Clinical-Based Studies.
    Nagasawa S; Takahashi J; Suzuki G; Hideya Y; Yamada K
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33808722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent Cisplatin-Based Chemoradiation in Squamous Cell Carcinoma of Cervix.
    Hashmi H; Maqbool A; Ahmed S; Ahmed A; Sheikh K; Ahmed A
    J Coll Physicians Surg Pak; 2016 Apr; 26(4):302-5. PubMed ID: 27097702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side Effect Profile.
    Federico C; Sun J; Muz B; Alhallak K; Cosper PF; Muhammad N; Jeske A; Hinger A; Markovina S; Grigsby P; Schwarz JK; Azab AK
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1483-1494. PubMed ID: 33253820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemoradiotherapy in cancers of the uterine cervix].
    Maingon P; Coucke P; Haie-Méder C; Barillot I
    Cancer Radiother; 1998 Dec; 2(6):718-22. PubMed ID: 9922779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
    Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
    BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late toxicities in concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy plus weekly cisplatin for locally advanced cervical cancer: a historical cohort comparison against two previous different treatment schemes.
    Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ
    Eur J Gynaecol Oncol; 2010; 31(5):504-9. PubMed ID: 21061789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent chemoradiotherapy with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts.
    Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z
    Clin Transl Oncol; 2014 Jun; 16(6):567-72. PubMed ID: 24105048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.